NFJ Investment Group LLC raised its position in Exponent, Inc. (NASDAQ:EXPO) by 161.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 29,310 shares of the business services provider’s stock after buying an additional 18,087 shares during the period. NFJ Investment Group LLC’s holdings in Exponent were worth $2,615,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Van ECK Associates Corp acquired a new stake in shares of Exponent in the 1st quarter valued at about $33,000. SRS Capital Advisors Inc. acquired a new stake in shares of Exponent in the 2nd quarter valued at about $33,000. Cullen Frost Bankers Inc. acquired a new stake in shares of Exponent in the 2nd quarter valued at about $44,000. Lazard Asset Management LLC acquired a new stake in shares of Exponent in the 1st quarter valued at about $46,000. Finally, Rational Advisors LLC acquired a new stake in shares of Exponent in the 2nd quarter valued at about $87,000. 89.50% of the stock is owned by institutional investors.
EXPO opened at $119.55 on Friday. The firm has a market cap of $6.22 billion, a price-to-earnings ratio of 66.05 and a beta of 0.36. Exponent, Inc. has a fifty-two week low of $68.42 and a fifty-two week high of $120.14. The company’s 50-day moving average price is $111.32 and its 200 day moving average price is $99.83.
The company also recently declared a quarterly dividend, which was paid on Friday, September 24th. Shareholders of record on Friday, September 10th were paid a $0.20 dividend. The ex-dividend date was Thursday, September 9th. This represents a $0.80 annualized dividend and a dividend yield of 0.67%. Exponent’s payout ratio is currently 51.61%.
A number of brokerages have recently issued reports on EXPO. Truist Securities upped their target price on shares of Exponent from $100.00 to $118.00 and gave the company a “buy” rating in a research note on Monday, August 2nd. Truist increased their price objective on shares of Exponent from $100.00 to $118.00 and gave the stock a “buy” rating in a research note on Monday, August 2nd. Finally, Zacks Investment Research lowered shares of Exponent from a “buy” rating to a “hold” rating in a research note on Wednesday.
In other news, VP Steven J. Murray sold 6,828 shares of the stock in a transaction that occurred on Tuesday, August 3rd. The shares were sold at an average price of $108.03, for a total value of $737,628.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Carol Lindstrom sold 880 shares of the stock in a transaction that occurred on Friday, August 27th. The shares were sold at an average price of $113.54, for a total transaction of $99,915.20. Following the completion of the transaction, the director now owns 5,248 shares of the company’s stock, valued at $595,857.92. The disclosure for this sale can be found here. Insiders sold 56,583 shares of company stock worth $6,406,594 in the last 90 days. 1.80% of the stock is owned by company insiders.
Exponent, Inc is an engineering and scientific consulting company, which engages in the provision of engineering, scientific, environmental, and health consulting services. It operates through the following segments: Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment include technical consulting in different practices primarily in engineering.
Further Reading: How does equity income fit into an investing strategy?
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.